The effects of safinamide on dysphagia in Parkinson’s disease
Dysphagia is a potentially fatal symptom of Parkinson’s disease (PD) and is characterized by frequent silent aspiration, a risk factor for aspiration pneumonia. The transdermal dopamine agonist rotigotine alleviates dysphagia in patients with PD and is more effective than oral levodopa, suggesting t...
Main Authors: | Makito Hirano, Makoto Samukawa, Chiharu Isono, Yoshitaka Nagai |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2023-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10212188/?tool=EBI |
Similar Items
-
The effects of safinamide on dysphagia in Parkinson's disease.
by: Makito Hirano, et al.
Published: (2023-01-01) -
The effect of rasagiline on swallowing function in Parkinson's disease
by: Makito Hirano, et al.
Published: (2024-01-01) -
Effects of safinamide on pain in patients with fluctuating Parkinson's disease
by: Sotirios Grigoriou, et al.
Published: (2021-10-01) -
SURINPARK: Safinamide for Urinary Symptoms in Parkinson’s Disease
by: Ana Gómez-López, et al.
Published: (2021-01-01) -
Safinamide: an add-on treatment for managing Parkinson’s disease
by: Müller T
Published: (2018-04-01)